Chronic hepatitis B (CHB) is caused by the Hepatitis B virus (HBV) and affects millions of people worldwide. Developing an effective CHB therapy requires using in vivo screening methods, such as mouse models reflecting CHB based on hydrodynamic delivery of plasmid vectors containing a replication-competent HBV genome. However, long-term expression of HBV proteins is accompanied by production of progeny virions, thereby requiring a Biosafety Level (BSL) 3 animal facility. In the present study, we introduced a point mutation in the START codon of the HBV polymerase to develop a mouse model reflecting chronic hepatitis B infection without formation of viral progeny. We induced the mouse model by hydrodynamic injection of adeno-associated virus plasmid vector (pAAV) and minicircle plasmid (pMC) constructs into C57Bl/6 and C3H/HeN mouse strains, monitoring HBV antigens and antibodies in blood by enzyme-linked immunosorbent assay and analyzing liver expression of HBV core antigen by immunohistology. Persisting expression of viral antigens over 140 days (study endpoint) was observed only in the C3H/HeN mouse strain when using pAAV/1.2HBV-A and pMC/1.0HBV-D with pre-C and pre-S recombination sites. In addition, pAAV/1.2HBV-A in C3H/HeN sustained HBV core antigen positivity up to the study endpoint in C3H/HeN mice. Moreover, introducing the point mutation in the START codon of polymerase effectively prevented the formation of viral progeny. Our study establishes an accessible and affordable experimental paradigm for developing a robust mouse model reflecting CHB suitable for preclinical testing of anti-HBV therapeutics in a BSL2 animal facility.

Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences Prague Czech Republic

See more in PubMed

Sunbul M. Hepatitis B virus genotypes: Global distribution and clinical importance. World J Gastroenterol. 2014;20:5427–5434. doi: 10.3748/wjg.v20.i18.5427. PubMed DOI PMC

World Health Organization. Global Hepatitis Report 2017. 2017

Krajden M, McNabb G, Petric M. The laboratory diagnosis of hepatitis B virus. Can J Infect Dis Med Microbiol. 2005;16:65–72. doi: 10.1155/2005/450574. PubMed DOI PMC

Ha HL, Shin HJ, Feitelson MA, Yu DY. Oxidative stress and antioxidants in hepatic pathogenesis. World J Gastroenterol. 2010;16:6035–6043. doi: 10.3748/wjg.v16.i48.6035. PubMed DOI PMC

Liu L, Yang F. Application of modified mesenchymal stem cells transplantation in the treatment of liver injury. Physiol Res. 2021;70:327–343. doi: 10.33549/physiolres.934623. PubMed DOI PMC

Farghali H, Kgalalelo Kemelo M, Wojnarová L, Kutinová Canová N. In vitro and in vivo experimental hepatotoxic models in liver research: applications to the assessment of potential hepatoprotective drugs. Physiol Res. 2016;65(Suppl 4):S417–S425. doi: 10.33549/physiolres.933506. PubMed DOI

Akbar SMF, Al Mahtab M, Aguilar JC, Yoshida O, Khan S, Penton E, Gerardo GN, Hiasa Y. The Safety and Efficacy of a Therapeutic Vaccine for Chronic Hepatitis B: A Follow-Up Study of Phase III Clinical Trial. Vaccines (Basel) 2022;10:45. doi: 10.3390/vaccines10010045. PubMed DOI PMC

Leowattana W, Leowattana T. Chronic hepatitis B: New potential therapeutic drugs target. World J Virol. 2022;11:57. doi: 10.5501/wjv.v11.i1.57. PubMed DOI PMC

Liu T, Sun Q, Gu J, Cen S, Zhang Q. Characterization of the tenofovir resistance-associated mutations in the hepatitis B virus isolates across genotypes A to D. Antiviral Res. 2022;203:105348. doi: 10.1016/j.antiviral.2022.105348. PubMed DOI

Wieland SF. The chimpanzee model for hepatitis B virus infection. Cold Spring Harb Perspect Med. 2015;5:a021469. doi: 10.1101/cshperspect.a021469. PubMed DOI PMC

Summers J, Smolec JM, Snyder R. A virus similar to human hepatitis B virus associated with hepatitis and hepatoma in woodchucks. Proc Natl Acad Sci U S A. 1978;75:4533. doi: 10.1073/pnas.75.9.4533. PubMed DOI PMC

Mason WS, Seal G, Summers J. Virus of Pekin ducks with structural and biological relatedness to human hepatitis B virus. J Virol. 1980;36:829. doi: 10.1128/jvi.36.3.829-836.1980. PubMed DOI PMC

Marion PL, Oshiro LS, Regnery DC, Scullard GH, Robinson WS. A virus in Beechey ground squirrels that is related to hepatitis B virus of humans. Proc Natl Acad Sci U S A. 1980;77:2941. doi: 10.1073/pnas.77.5.2941. PubMed DOI PMC

Guidotti LG, Matzke B, Schaller H, Chisari FV. High-level hepatitis B virus replication in transgenic mice. J Virol. 1995;69:6158–6169. doi: 10.1128/jvi.69.10.6158-6169.1995. PubMed DOI PMC

Grompe M, Al-Dhalimy M, Finegold M, Ou CN, Burlingame T, Kennaway NG, Soriano P. Loss of fumarylacetoacetate hydrolase is responsible for the neonatal hepatic dysfunction phenotype of lethal albino mice. Genes Dev. 1993;7:2298–2307. doi: 10.1101/gad.7.12a.2298. PubMed DOI

Wu LL, Wang HY, Chen PJ. Hydrodynamic HBV transfection mouse model. Methods Mol Biol. 2017;1540:227–235. doi: 10.1007/978-1-4939-6700-1_19. PubMed DOI

Yan Z, Zeng J, Yu Y, Xiang K, Hu H, Zhou X, Gu L, Wang L, Zhao J, Young JAT, Gao L. HBVcircle: A novel tool to investigate hepatitis B virus covalently closed circular DNA. J Hepatol. 2017;66:1149–1157. doi: 10.1016/j.jhep.2017.02.004. PubMed DOI

Ortega-Prieto AM, Cherry C, Gunn H, Dorner M. In vivo model systems for hepatitis B virus research. ACS Infect Dis. 2019;5:688–702. doi: 10.1021/acsinfecdis.8b00223. PubMed DOI PMC

Milich DR, Leroux-Roels GG. Immunogenetics of the response to HBsAg vaccination. Autoimmun Rev. 2003;2:248–257. doi: 10.1016/S1568-9972(03)00031-4. PubMed DOI

Peng XH, Ren XN, Chen LX, Shi BS, Xu CH, Fang Z, Liu X, Chen JL, Zhang XN, Hu YW, Zhou XH. High persistence rate of hepatitis B virus in a hydrodynamic injection-based transfection model in C3H/HeN mice. World J Gastroenterol. 2015;21:3527–3536. doi: 10.3748/wjg.v21.i12.3527. PubMed DOI PMC

Santantonio T, Jung MC, Pastore G, Angarano G, Günther S, Will H. Familial clustering of HBV pre-C and pre-S mutants. J Hepatol. 1997;26:221–227. doi: 10.1016/S0168-8278(97)80034-7. PubMed DOI

Huang LR, Wu HL, Chen PJ, Chen DS. An immunocompetent mouse model for the tolerance of human chronic hepatitis B virus infection. Proc Natl Acad Sci U S A. 2006;103:17862–17867. doi: 10.1073/pnas.0608578103. PubMed DOI PMC

Wang D, Tai PWL, Gao G. Adeno-associated virus vector as a platform for gene therapy delivery. Nat Rev Drug Discov. 2019;18:358–378. doi: 10.1038/s41573-019-0012-9. PubMed DOI PMC

Guo X, Chen P, Hou X, Xu W, Wang D, Wang TY, Zhang L, Zheng G, Gao ZL, He CY, Zhou B, Chen ZY. The recombined cccDNA produced using minicircle technology mimicked HBV genome in structure and function closely. Sci Rep. 2016;6:25552. doi: 10.1038/srep25552. PubMed DOI PMC

Wang L, Cao M, Wei QL, Zhao ZH, Xiang Q, Wang HJ, Zhang HT, Lai GQ. A new model mimicking persistent HBV e antigen-negative infection using covalently closed circular DNA in immunocompetent mice. PLoS One. 2017;12:e0175992. doi: 10.1371/journal.pone.0175992. PubMed DOI PMC

Chou HH, Chien WH, Wu LL, Cheng CH, Chung CH, Horng JH, Ni YH, et al. Age-related immune clearance of hepatitis B virus infection requires the establishment of gut microbiota. Proc Natl Acad Sci U S A. 2015;112:2175–2180. doi: 10.1073/pnas.1424775112. PubMed DOI PMC

Li L, Li S, Zhou Y, Yang L, Zhou D, Yang Y, Lu M, Yang D, Song J. The dose of HBV genome contained plasmid has a great impact on HBV persistence in hydrodynamic injection mouse model. Virol J. 2017;14:1–12. doi: 10.1186/s12985-017-0874-6. PubMed DOI PMC

Suda T, Liu D. Hydrodynamic delivery. Adv Genet. 2015;89:89–111. doi: 10.1016/bs.adgen.2014.10.002. PubMed DOI

Sun Y, Qi Y, Peng B, Li W. NTCP-reconstituted in vitro HBV infection system. Methods Mol Biol. 2017;1540:1–14. doi: 10.1007/978-1-4939-6700-1_1. PubMed DOI

Du Y, Broering R, Li X, Zhang X, Liu J, Yang D, Lu M. In vivo mouse models for hepatitis B virus infection and their application. Front Immunol. 2021;12:4578. doi: 10.3389/fimmu.2021.766534. PubMed DOI PMC

Řezáčová P, Pokorná J, Brynda J, Kožíšek M, Cígler P, Lepšík M, Fanfrlík J, et al. Design of HIV protease inhibitors based on inorganic polyhedral metallacarboranes. J Med Chem. 2009;52:7132–7141. doi: 10.1021/jm9011388. PubMed DOI

Kao JH. Diagnosis of hepatitis B virus infection through serological and virological markers. Expert Rev Gastroenterol Hepatol. 2008;2:553–562. doi: 10.1586/17474124.2.4.553. PubMed DOI

Kramvis A. Genotypes and genetic variability of hepatitis B virus. Intervirology. 2014;57:141–150. doi: 10.1159/000360947. PubMed DOI

Sengupta S, Rehman S, Durgapal H, Acharya SK, Panda SK. Role of surface promoter mutations in hepatitis B surface antigen production and secretion in occult hepatitis B virus infection. J Med Virol. 2007;79:220–228. doi: 10.1002/jmv.20790. PubMed DOI

Zhou T, Guo H, Guo JT, Cuconati A, Mehta A, Block TM. Hepatitis B virus e antigen production is dependent upon covalently closed circular (ccc) DNA in HepAD38 cell cultures and may serve as a cccDNA surrogate in antiviral screening assays. Antiviral Res. 2006;72:116–124. doi: 10.1016/j.antiviral.2006.05.006. PubMed DOI

Levrero M, Pollicino T, Petersen J, Belloni L, Raimondo G, Dandri M. Control of cccDNA function in hepatitis B virus infection. J Hepatol. 2009;51:581–592. doi: 10.1016/j.jhep.2009.05.022. PubMed DOI

The World Health Organisation. Guidelines on Hepatitis B and C Testing. 2017